Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

ClinicalTrials.gov ID: NCT00465088

Public ClinicalTrials.gov record NCT00465088. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

SUPREME: A 12-Week, Open-Label, Multicenter Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia

Study identification

NCT ID
NCT00465088
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
199 participants

Conditions and interventions

Interventions

  • Niacin ER/Simvastatin Tablets Drug
  • atorvastatin Drug

Drug

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2007
Primary completion
Jan 31, 2008
Completion
Not listed
Last update posted
Jun 12, 2011

Started 2007

United States locations

U.S. sites
46
U.S. states
18
U.S. cities
46
Facility City State ZIP Site status
Not listed Anaheim California 92801
Not listed Huntington Park California 90255
Not listed Long Beach California 90822
Not listed Sacramento California 95825
Not listed Walnut Creek California 94598
Not listed Brooksville Florida 34613
Not listed Daytona Beach Florida 32117
Not listed Gainesville Florida 32605
Not listed Largo Florida 33770
Not listed Merritt Island Florida 32953
Not listed Miami Florida 33126
Not listed Pembroke Pines Florida 33026
Not listed Calhoun Georgia 30701
Not listed Decatur Georgia 30034
Not listed Dunwoody Georgia 30338
Not listed Boise Idaho 83704
Not listed Chicago Illinois 60607
Not listed Arkansas City Kansas 67005
Not listed Newton Kansas 67114
Not listed Shawnee Mission Kansas 66216
Not listed Topeka Kansas 55508
Not listed Wichita Kansas 67203
Not listed Auburn Maine 04210
Not listed Baltimore Maryland 21204
Not listed Missoula Montana 59808
Not listed Charlotte North Carolina 28204
Not listed High Point North Carolina 27262
Not listed Canfield Ohio 44406
Not listed Cincinnati Ohio 45242
Not listed Dayton Ohio 45458
Not listed Protland Oregon 97239
Not listed Chicora Pennsylvania 16025
Not listed Duncansville Pennsylvania 16635
Not listed Harleysville Pennsylvania 19438
Not listed Pittsburgh Pennsylvania 15206
Not listed Austin Texas 78752
Not listed Carrollton Texas 75006
Not listed Dallas Texas 75251
Not listed Houston Texas 77074
Not listed San Antonio Texas 78224
Not listed Magna Utah 84044
Not listed Salt Lake City Utah 84107
Not listed Richmond Virginia 23249
Not listed Gig Harbor Washington 98335
Not listed Menomonee Falls Wisconsin 53051
Not listed Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00465088, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2011 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00465088 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →